Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors
- DOI
- 10.1101/2023.08.01.551480
- Published
- 2023-08-03
- Container
- Not recorded
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1101/2023.08.01.551480,
title = {Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors},
author = {Sklavenitis-Pistofidis R and Lightbody ED and Reidy M and Tsuji J and Aranha MP and Heilpern-Mallory D and Huynh D and Chong SJF and Hackett L and Haradhvala NJ and Wu T and Su NK and Berrios B and Alberge J and Dutta A and Davids MS and Papaioannou M and Getz G and Ghobrial IM and Manier S.},
year = {2023},
doi = {10.1101/2023.08.01.551480},
url = {https://doi.org/10.1101/2023.08.01.551480}
}RIS
TY - JOUR TI - Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors AU - Sklavenitis-Pistofidis R AU - Lightbody ED AU - Reidy M AU - Tsuji J AU - Aranha MP AU - Heilpern-Mallory D AU - Huynh D AU - Chong SJF AU - Hackett L AU - Haradhvala NJ AU - Wu T AU - Su NK AU - Berrios B AU - Alberge J AU - Dutta A AU - Davids MS AU - Papaioannou M AU - Getz G AU - Ghobrial IM AU - Manier S. PY - 2023 DO - 10.1101/2023.08.01.551480 UR - https://doi.org/10.1101/2023.08.01.551480 ER -
APA
R, S., ED, L., M, R., J, T., MP, A., D, H., D, H., SJF, C., L, H., NJ, H., T, W., NK, S., B, B., J, A., A, D., MS, D., M, P., G, G., IM, G., & S., M. (2023). Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors. https://doi.org/10.1101/2023.08.01.551480
Source records
- europe-pmc · retrieved 2026-09-26T17:05:47.211Z